Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's morning session, 29 stocks hit new 52-week lows.
Panbela Therapeutics Shares Drop On Raising $10M Via Equity Issued At 21% Discount
Panbela Therapeutics Inc (NASDAQ:PBLA) has increased the size of the previously announced public offering to around 3.3 million common shares from 1.7…
The Daily Biotech Pulse: COVID Disappointments For Altimmune And Angion, Brickell Jumps On Hyperhidrosis Study Updates, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 29)
29 Stocks Moving in Wednesday’s Pre-Market Session
Gainers
Bridgeline Digital, Inc. (NASDAQ: BLIN) shares rose 83% to $6.20 in pre-market trading. Bridgeline Digital shares jumped over 36% on Tuesday on above-average volume.
Panbela Therapeutics Announces $5M Bought Deal Offering Of Common Stock
Panbela Therapeutics, Inc. (NASDAQ:PBLA) (the "Company" or "Panbela"), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, today
Roth Capital Initiates Coverage On Panbela Therapeutics with Buy Rating, Announces Price Target of $10
Roth Capital analyst Tony Butler initiates coverage on Panbela Therapeutics (NASDAQ:PBLA) with a Buy rating and announces Price Target of $10.
The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes
After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-specific news flow dictated stock moves during the week.